Toronto, Ontario--(Newsfile Corp. - September 13, 2022) - ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to announce that its wholly owned subsidiary, Concierge Medical Consultants Inc. ("Concierge"), has introduced Intravenous Vitamin Therapy (IV Therapy) to its services in Toronto and Vancouver.
The Company has launched this new service with six (6) variations of Vitamindrip® products:
1)Hydration - A combination of IV hydration and vitamin additives to immediately eliminate dehydration in the body.
2)Recovery - This type of IV reduces cold and flu symptoms by booting the immune system.
3)Energy - Promotes adrenal function, mental alertness, and stress tolerance.
4)Cosmetic - Enriched with amino acids and active ingredients to repair and stimulate collagen growth naturally within your body.
5)Diet and Detox - Instantly detoxifies your body and boosts your energy with healthy vitamins to flush out unhealth toxins.
6)Immune Boost - Boost the body's immune system with vitamins, minerals, and amino acids.
Vitamindrip® products are used in hospitals and by healthcare professionals worldwide. Vitamindrip® is a scientifically formulated intravenous solution for effective treatment of moderate to severe dehydration, and has been found to be effective against asthma, migraines, fatigue, acute muscle spasm, upper respiratory tract infections, chronic sinusitis, seasonal allergic rhinitis, and other disorders. (Source: https://www.vitamindrip.com/science)
Infused with electrolytes and vitamins, IV Therapy provides immediate hydration into the bloodstream. Patients will experience a boost in energy levels and instantly feel replenished. IV Therapy removes toxins from the body and is an effective treatment to put nutrients back into the body, optimizing patient's overall health. (Source: https://www.vitamindrip.com/science)
"IV Therapy has seen tremendous demand and growth in the market. It also continues to be trending in popularity in the health and wellness industry. From boosting the immune system to helping patients achieve their best health with fast recovery, we are very excited to add this new service", said Andrew Ryu, interim CEO and Chairman of the Company.
To learn more about Concierge Medical's IV Therapy, visit: https://www.conciergemedical.ca/ivvitamintherapy.
To book an IV Vitamin Therapy Service, please visit: https://conciergemedicalca.janeapp.com/staff_member/9.
For Further Information:
Toronto Office: 289-681-2300
Vancouver Office: 778-883-6334
For additional information and inquiries on Concierge Medical services please contact info@conciergemedical.ca
About ScreenPro
ScreenPro is a medical technology company that provides turnkey screening solutions with its proprietary medical alerting software. ScreenPro's unique access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in British Columbia, Ontario and Quebec allows ScreenPro to be a full-service nationwide provider of COVID testing and breast cancer screening solutions across Canada. In addition, ScreenPro's subsidiary, Concierge Medical, is a group of board-certified physicians who provide private, discreet, and personalized healthcare to Canadians. ScreenPro prides itself in having its own medical doctors and nursing professionals with on the ground support staff and transportation, with access to high quality PPEs to ensure that clients are protected in all aspects of their testing needs. ScreenPro also newly introduced Naturevan Nutrition Ltd., to its portfolio, providing vitamins and supplements that are proudly made in Canada and distributed for sale online.
For additional information on ScreenPro and other corporate information, please visit the Company's website at www.screenprosecurity.com
For more information about the Company, please refer to the Company's profile on SEDAR at www.sedar.com.
Neither the Canadian Securities Exchange (the "CSE") nor it's Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
For further information:
Investor Relations & Communications
Priya Monique Atwal, Director of Communications
Tel: (416) 901-5611 x 204
Email: priya@screenprosecurity.com
Andrew Ryu, Interim Chief Executive Officer and Chairman
Tel: 416-901-5611 x 201
Email: aryu@datametrex.com
Forward Looking Statements:
Certain statements contained in this news release may constitute forward-looking information, including statements relating to the future development of ScreenPro's business. Forward-looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. The actual results of ScreenPro could differ materially from those anticipated in this forward-looking information as a result of regulatory decisions, competitive factors in the industries in which ScreenPro operates, prevailing economic conditions, changes to ScreenPro's strategic growth plans, and other factors, many of which are beyond the control of ScreenPro. Management of ScreenPro believes that the expectations reflected in the forward-looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information should not be unduly relied upon. Any forward-looking information contained in this news release represents ScreenPro's expectations as of the date hereof and is subject to change after such date. ScreenPro disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.
###
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/136955
